How to Sell Dermatology Practice in 2026: Owner Guide
- Right Fit Capital
- 6 days ago
- 10 min read
If you want to sell dermatology practice ownership in 2026, the market is still active, but buyers are more selective than they were during the fastest roll-up years. Strong practices can attract serious interest from private equity-backed platforms, regional dermatology groups, strategic healthcare buyers, and individual physicians. But the best outcome depends on more than finding a buyer. It depends on preparing the practice, protecting confidentiality, comparing deal structures, and choosing the buyer whose plan actually fits your future.
Dermatology remains attractive because it combines recurring medical demand, procedural revenue, cosmetic and aesthetic services, ancillary upside, and a still-fragmented independent practice base. Recent 2026 market commentary from FOCUS Investment Banking describes dermatology as an active and resilient M&A category, with small to mid-sized practices trading in a broad range depending on profitability, payor mix, service mix, and operational maturity. A January 2026 Dermatology Times market update also noted that private equity buyers are re-entering the space, but with deeper diligence and more emphasis on clinical quality, infrastructure, and long-term stability.
That is the practical reality for owners: the market is not closed, but it is not automatic. A dermatology practice with clean financials, a balanced service mix, provider continuity, staff stability, and a credible transition plan will be viewed very differently from a practice that is profitable but completely dependent on one owner-doctor.
Why Dermatology Practices Are Attractive to Buyers
Dermatology has several traits that appeal to healthcare acquirers. Medical dermatology creates recurring patient demand through skin checks, chronic condition management, acne, psoriasis, eczema, and other ongoing care needs. Surgical dermatology and Mohs surgery can add procedural depth. Cosmetic dermatology, lasers, injectables, medspa services, and skin-care product sales can create higher-margin, cash-pay revenue streams when managed well.
Buyers also like specialties where there is room to consolidate. Many dermatology practices are still independent, locally known, and physician-owned. A buyer with a platform strategy may want to build regional density, centralize administrative functions, recruit providers, add service lines, improve marketing, and use scale to strengthen payor, purchasing, and operating leverage.
Recent transaction activity supports that continued interest. In April 2026, AQUA Dermatology announced a partnership with Steele Dermatology, a private dermatology practice with two Atlanta-area locations, highlighting the target's blend of cosmetic and medical dermatology. The deal is only one example, but it shows what buyers are often looking for: established local reputation, service-line mix, provider continuity, and market fit.
How to Sell Dermatology Practice Without Losing Control
To sell dermatology practice ownership well, start by treating the transaction as a controlled process, not a casual conversation with whichever buyer reaches out first. Many owners receive inbound interest from a platform, broker, regional group, or private equity-backed management services organization. That can be useful, but it should not define the whole strategy.
A good process answers five questions before sensitive information is shared broadly:
What outcome does the owner want? Full exit, partial liquidity, continued clinical work, reduced administration, growth support, or succession planning.
Which buyer types are realistic? Private equity-backed dermatology platform, larger regional group, strategic healthcare buyer, hospital-affiliated buyer, individual dermatologist, or internal associate.
What is the practice likely worth? Based on adjusted earnings, provider risk, service mix, payor mix, growth, location, ancillaries, and buyer fit.
What information should be shared first? Anonymous overview, high-level financials, provider count, service mix, geography, and owner goals before deeper diligence.
What must be protected? Staff stability, patient trust, referral relationships, physician contracts, compensation information, lease terms, and culture.
Owners often focus first on price. Price matters, but it is only one part of the transaction. A disciplined process helps you compare buyers on certainty, structure, timeline, post-sale role, cultural fit, and the buyer's plan for the practice after closing.
Step 1: Clarify Your Sale Goals Before Talking to Buyers
Before buyer conversations begin, define what a successful transition would look like. A 65-year-old owner who wants to retire within 12 months has a different goal from a 45-year-old dermatologist who wants to de-risk financially, keep practicing, and help build a regional platform. A multi-provider practice with growth ambitions has different options than a solo practice where the owner is the primary revenue engine.
Useful questions include:
Do you want to fully exit, or keep working after closing?
How long are you willing to stay for a transition period?
Would you consider rollover equity in a larger platform?
How important is preserving the practice name, culture, and clinical autonomy?
Are staff retention and associate physician stability major concerns?
Do you want the highest headline price, the most cash at close, the fastest close, or the cleanest post-sale life?
Would you rather sell to a corporate platform, another physician group, an individual dermatologist, or an internal successor?
The clearer your goals are, the easier it becomes to avoid buyers who look attractive on paper but are wrong for the practice.
Step 2: Understand What Your Dermatology Practice Is Worth
Most dermatology transactions are valued around adjusted earnings, not simply revenue. Buyers usually look at EBITDA or seller's discretionary earnings after normalizing owner compensation, personal expenses, one-time costs, related-party arrangements, and other add-backs. The stronger and more transferable those earnings are, the more competitive the practice can become.
Common valuation drivers include:
Scale: revenue, adjusted EBITDA, number of providers, number of locations, and patient volume.
Provider bench: associate dermatologists, physician assistants, nurse practitioners, Mohs surgeons, aestheticians, and dependence on the selling owner.
Service mix: medical dermatology, surgical dermatology, Mohs, pathology, cosmetics, medspa, lasers, injectables, and retail skin-care revenue.
Payor mix: commercial, Medicare, Medicaid, cash-pay, and out-of-network exposure.
Margin quality: whether profit is sustainable after market-rate provider compensation.
Operational maturity: billing, collections, staffing, scheduling, EMR, marketing, compliance, and documented workflows.
Geography: market growth, competition, reimbursement environment, provider recruiting, and buyer density.
Growth story: unused capacity, new service lines, referral growth, de novo opportunity, or better utilization of existing providers.
Valuation ranges in dermatology can vary widely. A smaller owner-dependent practice may be valued very differently from a multi-provider group with strong EBITDA, Mohs capability, cosmetic revenue, and management infrastructure. The goal is not to chase a generic multiple. The goal is to understand which buyers would underwrite your specific practice most favorably and why.
Step 3: Prepare the Practice Before Diligence Starts
Buyers form opinions quickly. If the financials are messy, provider agreements are unclear, or the owner cannot explain recent trends, the buyer may still be interested, but confidence drops. Lower confidence can become a lower valuation, more structure, longer diligence, or a failed closing.
Before going to market, prepare these areas:
Financial statements: clean profit and loss statements, balance sheets, tax returns, production reports, add-back schedule, and owner compensation detail.
Provider data: production by provider, schedules, employment agreements, compensation models, tenure, credentialing, and non-solicitation or non-compete terms where applicable.
Revenue detail: medical, surgical, cosmetic, medspa, pathology, product sales, payor mix, patient volume, procedure mix, and referral sources.
Operations: staffing model, billing process, collections performance, scheduling capacity, EMR, marketing, compliance, and key vendors.
Facilities: lease terms, renewal options, equipment list, capital expenditure needs, and expansion capacity.
Risks: litigation, payor issues, billing audits, HR issues, expired contracts, key-person dependencies, and any recent declines in production.
Do not wait for diligence to uncover the weak points. If a problem exists, understand it, document it, and decide how to explain it. Buyers can handle imperfections. They are less comfortable with surprises.
Step 4: Choose the Right Buyer Type
Different buyers value different things. A private equity-backed platform may pay more for scale, provider bench, cosmetic mix, ancillaries, and regional density. An individual dermatologist may care more about affordability, financing, lifestyle, and local continuity. A regional dermatology group may understand your market and move with less institutional friction. A strategic healthcare buyer may care about referral patterns, geography, or integration with adjacent services.
The main buyer paths are:
Private equity-backed dermatology platforms: often interested in add-on acquisitions, regional density, infrastructure, and growth potential. These deals may involve cash at close, rollover equity, employment agreements, and management services structures.
Regional dermatology groups: may offer a more practice-focused transition with buyer familiarity in your geography.
Individual dermatologists: can be a strong cultural fit, but may face financing limitations, especially for larger practices.
Internal associates: may preserve continuity, though many associates need financing support, seller financing, or a staged buyout.
Strategic healthcare buyers: may be relevant when the practice fits a broader specialty, health system, MSO, or outpatient services strategy.
For general buyer strategy, Right Fit Capital's articles on where to find strategic buyers and selling to private equity vs. an individual buyer are useful companion reads.
Step 5: Protect Confidentiality From the First Conversation
Confidentiality matters in a dermatology sale because rumors can unsettle physicians, PAs, NPs, aestheticians, staff, patients, landlords, vendors, and competitors. A practice sale should not become public just because an owner wants to understand the market.
A controlled process usually starts with an anonymous or lightly blinded overview. Early materials may describe the general region, practice type, approximate size, provider count, service mix, and owner goals without naming the practice or sharing detailed financials. More sensitive information should come later, after buyer screening and an NDA.
Information to protect early includes:
Practice name and exact address
Provider and employee names
Detailed compensation information
Patient lists or identifiable patient information
Tax returns and full financial records
Lease documents
Payor contracts
Detailed production reports
Vendor agreements and compliance materials
Confidentiality is not just about signing an NDA. It is about staged disclosure, buyer screening, controlled document sharing, and knowing who inside the buyer organization will see the information.
Step 6: Compare Deal Structure, Not Just Price
When owners sell dermatology practice assets, the headline valuation can be misleading if the structure is complicated. Two offers can look similar but produce very different results after closing.
Terms to compare include:
Cash at close: how much money is paid immediately and whether any portion is held back.
Rollover equity: whether you reinvest part of your proceeds into the buyer platform, how that equity is valued, what rights you have, and what must happen for a second payout.
Earn-outs: whether future payments depend on revenue, EBITDA, provider retention, patient volume, or other targets.
Employment agreement: compensation, schedule, productivity expectations, term, restrictive covenants, clinical duties, and administrative responsibilities.
Governance: what decisions remain with physicians and what decisions move to the platform or management company.
Working capital and adjustments: whether the purchase price can change based on receivables, inventory, liabilities, or closing conditions.
Transition obligations: how long the seller must stay, what happens if the seller reduces hours, and who is responsible for recruiting replacement providers.
Rollover equity can be attractive, but it is not the same as cash. Earn-outs can bridge a valuation gap, but they shift some risk back to the seller. Employment terms can preserve continuity, but they can also change the owner's day-to-day life. A strong transaction is one where the economic terms and the post-sale reality both make sense.
Step 7: Know What Buyers Will Test in Diligence
Diligence is where buyers verify the story. They will test whether the reported earnings are real, whether revenue is durable, whether key providers will stay, whether the practice is compliant, and whether the buyer can operate the business after closing.
Expect diligence around:
Quality of earnings and add-backs
Payor mix, collections, reimbursement trends, and billing practices
Provider contracts, productivity, compensation, and retention risk
Procedure mix, cosmetic revenue, Mohs volume, pathology, and medspa economics
Patient volume, referral sources, online reputation, and marketing performance
Staff tenure, wage pressure, benefits, and turnover
Lease terms, equipment condition, facility capacity, and expansion potential
Compliance, privacy, licensure, coding, documentation, and any legal issues
A buyer that asks detailed questions is not necessarily a bad buyer. Serious buyers should ask hard questions. The issue is whether the buyer is credible, organized, respectful of confidentiality, and able to move from diligence to closing without constantly changing the deal.
Step 8: Plan the Post-Sale Transition Early
The sale does not end at signing. Dermatology buyers care about continuity because the value of the practice depends on providers, staff, patients, and reputation staying intact after closing.
Before choosing a buyer, understand:
How long the seller is expected to remain clinically active
Whether associate providers will receive new agreements
How staff benefits, compensation, titles, and reporting lines may change
Whether the practice name and brand will remain
How scheduling, billing, HR, purchasing, marketing, and compliance will be managed
What clinical autonomy will look like after closing
How patients will be told about the transition
Owners should not treat these as afterthoughts. The buyer's transition plan can affect staff morale, patient retention, provider satisfaction, and whether the owner feels good about the deal after the wire hits.
Common Mistakes When Selling a Dermatology Practice
Many practice owners lose leverage by starting too casually, sharing too much too soon, or focusing only on a buyer's headline valuation.
Common mistakes include:
Talking to only one buyer and assuming that offer reflects the market
Using revenue as a valuation shortcut without understanding adjusted earnings
Waiting until burnout or declining production weakens the story
Ignoring the employment agreement until late in the process
Accepting rollover equity without understanding the buyer's capital structure and exit path
Sharing detailed financials before screening the buyer
Failing to prepare staff and provider continuity plans
Letting diligence uncover problems the owner should have addressed earlier
Choosing the buyer with the highest stated price instead of the best overall fit
A better process is quieter, more deliberate, and more comparative. It gives the owner room to understand the market before committing to one path.
Should You Sell Now or Wait?
Waiting can make sense if the practice is growing, margins are improving, provider bench is expanding, and the owner still has the energy to keep building. If the next 12 to 24 months will make the practice materially stronger, waiting may improve buyer interest.
But waiting can also work against an owner. If production is declining, staff turnover is rising, reimbursement pressure is increasing, or the owner is reducing hours, the practice may look weaker later than it does now. Buyers pay for confidence in the future, not nostalgia for the practice's best year.
You do not need to decide immediately whether to sell. You can explore buyer interest confidentially, understand likely valuation range, compare buyer types, and decide whether the market is attractive enough to move forward.
How Right Fit Capital Helps Dermatology Owners Explore Options
Right Fit Capital helps healthcare practice owners explore potential buyer fit through a confidential, targeted process. For dermatology owners, that means clarifying goals, understanding likely buyer categories, preparing the practice story, and facilitating conversations with relevant buyers without immediately turning the process into a public listing.
Right Fit Capital's M&A matchmaking process is built for owners who want to understand their options before committing to a sale path. You can also review general process questions on the FAQ page or learn more about the types of practices Right Fit Capital supports on the Practices page.
Bottom Line: Sell Dermatology Practice Ownership With a Buyer-Fit Strategy
The 2026 dermatology M&A market still has real buyer interest, especially for practices with transferable earnings, provider continuity, cosmetic or ancillary upside, clean reporting, and a credible growth story. But the best transaction is not always the one with the loudest buyer or the highest first number.
If you are thinking about whether to sell dermatology practice ownership, start by understanding the buyer landscape, preparing your financial and operational story, protecting confidentiality, and comparing deal structures carefully. The right buyer should fit the business you built, the transition you want, and the future you are trying to create.
To explore buyer options confidentially, visit rightfitcapital.com and start a conversation with Right Fit Capital.
